15 pharma makers behind every label.
Pharmaceutical companies and US 503A compounding pharmacies — split, never blended. Research-use only suppliers live in their own directory.
Danish multinational pharmaceutical, world leader in diabetes care. Makers of Ozempic, Wegovy, Rybelsus (semaglutide), Saxenda/Victoza (liraglutide), and Norditropin (somatropin).
Indianapolis-based pharmaceutical company. Makers of Mounjaro and Zepbound (tirzepatide), Trulicity (dulaglutide), Humatrope (somatropin), Forteo (teriparatide).
Anglo-Swedish pharmaceutical. Originator of Byetta and Bydureon (exenatide) — exenatide rights have changed hands; AstraZeneca retains historical association.
French multinational pharmaceutical. Historical maker of Adlyxin/Lyxumia (lixisenatide) and ongoing diabetes franchise.
US pharmaceutical company (known as MSD outside the US and Canada).
Maker of Genotropin (somatropin) and other endocrinology medicines.
Canadian biopharma. Originator of Egrifta (tesamorelin).
Original US marketer of Vyleesi (bremelanotide / PT-141). Rights have since transferred.